The "New Elemental Impurities Tests for Pharmaceutical Products According to the New ICH Q3D and USP 232/233 Guidelines" webinar has been added to ResearchAndMarkets.com's offering.
This webinar will discuss the new elemental impurities test requirements as per the new ICH Q3D and USP 232/233 Guidelines, the testing required to comply with it and how to do proper risk assessment and analytical measurements, which drug products are within the scope, the documentation related to control of elemental impurity, which methods required to be validated.
The objective of this live training webinar is to provide an understanding of the new standards and guideline, what testing is required in order to comply with the spirit of the documents, how to perform a proper risk assessment, and how to perform suitable analytical measurements.
Areas Covered in the Webinar:
Who Should Attend:
For more information about this webinar visit https://www.researchandmarkets.com/research/h37j5d/new_elemental?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180713005377/en/